(Q37604504)

English

Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study

scientific article published on 07 June 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study (English)

1 reference

Europe PubMed Central

21 August 2017

0 references

object named as

Laura Obici

2

0 references

Helen J Lachmann

object named as

Helen J Lachmann

10

0 references

1

object named as

Marco Gattorno

1 reference

Europe PubMed Central

21 August 2017

author name string

Marco Cattalini

3

1 reference

Europe PubMed Central

21 August 2017

Vincent Tormey

4

1 reference

Europe PubMed Central

21 August 2017

Ken Abrams

5

1 reference

Europe PubMed Central

21 August 2017

Nicole Davis

6

1 reference

Europe PubMed Central

21 August 2017

Antonio Speziale

7

1 reference

Europe PubMed Central

21 August 2017

Suraj G Bhansali

8

1 reference

Europe PubMed Central

21 August 2017

Alberto Martini

9

1 reference

Europe PubMed Central

21 August 2017

language of work or name

0 references

publication date

7 June 2016

1 reference

Europe PubMed Central

21 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

21 August 2017

76

1 reference

Europe PubMed Central

21 August 2017

1

1 reference

Europe PubMed Central

21 August 2017

173-178

1 reference

Europe PubMed Central

21 August 2017

The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

An international registry on autoinflammatory diseases: the Eurofever experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

Use of canakinumab in the cryopyrin-associated periodic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

23 August 2017

Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

14 September 2017

Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

14 September 2017

Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

14 September 2017

Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): c

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

14 September 2017

Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

1 September 2018

Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

1 September 2018

Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

1 September 2018

Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5264215

1 September 2018

Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-209031

21 January 2018

Successful Treatment of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Canakinumab

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-209031

21 January 2018

Beneficial response to interleukin 1 receptor antagonist in traps

1 reference

https://pubmed.ncbi.nlm.nih.gov/27269295

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/27269295

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ANNRHEUMDIS-2015-209031

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37604504&oldid=1714136318"